active ingredient: ribavirin; 1 tablet contains 200 mg of ribavirin;
excipients: corn starch, sodium starch (type A), microcrystalline cellulose, corn starch, magnesium stearate. film shell: OPADRY® pink 03A14309 (hypromellose, talc, titanium dioxide (E 171), iron oxide yellow (E172), iron oxide red (E172)), ethylcellulose aqueous dispersion (solid), triacetin.
Treatment of chronic hepatitis C (CHC) in combination with other drugs.
Dosage & Administration
Therapy should carry a doctor who has experience in the treatment of chronic hepatitis C. Copegus® should be taken twice daily (morning and evening) during food intake. Due to the teratogenic potential of ribavirin tablets should not crush or grind.
Copegus be used in combination with peginterferon alfa-2a or interferon alfa-2a. The exact dose and duration depends on the drug interferon used.